HIGHLIGHTS
- who: Shu-Yein Ho et al. from the Division of Gastroenterology and Hepatology, Min-Sheng General Hospital, Taoyuan, Taiwan School of Medicine, National Chiao Tung University, Taipei, Taiwan have published the research: Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score, in the Journal: Cancers 2022, 14, 4207. of /2022/
- what: The authors aimed to evaluate the prognostic impact of TBS on HCC patients within the Milan criteria undergoing radiofrequency ablation (RFA) or transarterial chemoembolization (TACE). In this study, the long-term survival in a large patient . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.